Abstract:A class of exceptionally bioactive molecules known as reactive oxygen species (ROS) have been widely studied in the context of cancer. They play a significant role in the etiopathogenesis for cancer. Implication of ROS in cancer biology is an evolving area, considering the recent advances; insights into their generation, role of genomic and epigenetic regulators for ROS, earlier thought to be a chemical process, with interrelations with cell death pathways- Apoptosis, ferroptosis, necroptosis and autophagy has been explored for newer targets that shift the balance of ROS towards cancer cell death. ROS are signal transducers that induce angiogenesis, invasion, cell migration, and proliferation at low to moderate concentrations and are considered normal by-products of a range of biological activities. Although ROS is known to exist in the oncology domain since time immemorial, its excessive quantities are known to damage organelles, membranes, lipids, proteins, and nucleic acids, resulting in cell death. In the last two decades, numerous studies have demonstrated immunotherapies and other anticancer treatments that modulate ROS levels have promising in vitro and in vivo effects. This review also explores recent targets for therapeutic interventions in cancer that are based on ROS generation or inhibition to disrupt the cell oxidative stress balance. Examples include-metabolic targets, targeted therapy with biomarkers, natural extracts and nutraceuticals and targets developed in the area of nano medicine. In this review, we present the molecular pathways which can be used to create therapy plans that target cancer by regulating ROS levels, particularly current developments and potential prospects for the effective implementation of ROS-mediated therapies in clinical settings. The recent advances in complex interaction with apoptosis especially ferroptosis and its role in epigenomics and modifications are a new paradigm, to just mechanical action of ROS, as highlighted in this review. Their inhibition by nutraceuticals and natural extracts has been a scientific challenging avenue that is explored. Also, the inhibition of generation of ROS by inhibitors, immune modulators and inhibitors of apoptosis and ferroptosis is explored in this review.

Potential roles of reactive oxygen species derived from chemical substances involved in cancer development in the female reproductive system

Reactive Oxygen Species: A Key Constituent in Cancer Survival

Roles of Reactive Oxygen Species in Inflammation and Cancer

Controlling Cancer Cells Using Reactive Oxygen Species

Does each Component of Reactive Oxygen Species have a Dual Role in the Tumor Microenvironment?

Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements

Metabolic Regulation of Redox Balance in Cancer

Oxidative Stress in Cancer Cell Metabolism

Dual Role of Reactive Oxygen Species and their Application in Cancer Therapy

Reactive Oxygen Species Mechanisms that Regulate Protein–Protein Interactions in Cancer

The double-edged roles of ROS in cancer prevention and therapy

Recent advances and future directions in etiopathogenesis and mechanisms of reactive oxygen species in cancer treatment

Research progress on the role of reactive oxygen species in the initiation, development and treatment of breast cancer

ROS signalling in the biology of cancer

Modulation of reactive oxygen species in cancers: recent advances

Cancer Metabolism: The Role of ROS in DNA Damage and Induction of Apoptosis in Cancer Cells

Oxidative Stress and Redox-Dependent Signaling in Prostate Cancer

Reactive Oxygen and Nitrogen Species in Carcinogenesis: Implications of Oxidative Stress on the Progression and Development of Several Cancer Types

Understanding the Impact of Oxidative Stress on Ovarian Cancer: Advances in Diagnosis and Treatment

A Review of Reactive Oxygen Species and the Antioxidant System

The role of ROS in tumour development and progression